Can VEGFA and ICAM1 polymorphisms predict response to bevacizumab
2018
2521Background: Most targeted treatments are associated with biomarkers, predictive of drug response. Although bevacizumab is widely used, there are still no available biomarkers. Given the need of...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI